Navigation Links
New Study Suggests Better Patient Outcomes with CYPHER,Sirolimus-Eluting Coronary Stent than with Taxus Stent in,Real-World Clinical Settings

Registry Analysis Published in Journal Heart Finds Taxus Stent, Implantation of Multiple Stents and Small Vessel Size To Be Independent Predictors of Need for Another Procedure


MIAMI LAKES, Fla., June 4, 2007 /PRNewswire via COMTEX News Network/ -- An analysis of data from the Western Denmark Heart Registry found that patients who received the CYPHER(R) Sirolimus-eluting Coronary Stent to open a clogged artery were less likely to need another procedure at that same lesion site (a clinical event called target lesion revascularization or TLR) than patients who received a Taxus Stent. The analysis was published in the June 1 issue of the journal Heart.

The authors of the analysis sought to identify risk factors for symptom- driven TLR when patients were treated with the CYPHER(R) Stent or the Taxus Stent in a real-world scenario. From Jan. 1, 2003 to May 18, 2005, 4,432 patients in Western Denmark were treated with a drug-eluting stent (CYPHER(R) Stent: 2,728 patients; Taxus Stent: 1,704 patients). Use of a Taxus Stent (odds ratio of 1.43; p=0.022), implantation of multiple stents per lesion (odds ratio of 1.62; p=0.008) and stent implantation in small vessels (odds ratio of 1.42; p=0.049) were found to be independent predictors of the need for TLR at nine months after the procedure.

"The major new finding of this study was that the use of the Taxus Stent was an independent predictor of TLR for a real-world population of patients treated with the CYPHER(R) Stent and the Taxus Stent," said Michael Maeng, M.D., Principal Investigator, from Aarhus University Hospital, Denmark.

When the lesions were divided into subgroups according to vessel size, the CYPHER(R) Stent yielded a 20 percent relative reduction of TLR in large vessels (2.4 percent versus 3.0 percent in arteries with a reference diameter equal to or greater than 2.8 mm; p=not significant) and a 40 percent relative reductio
'"/>




Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:12/17/2014)... 2014  Strategic Health Services, Inc. (SHS), a leading ... a strategic agreement with QualCare, Inc., a leading provider of ... regional marketplace.  This agreement will further QualCare,s population ... solutions QualCare brings to its clients in ... QualCare plans cover more than 800,000 member ...
(Date:12/17/2014)... ANGELES , Dec. 17, 2014  ImmunoCellular ... the US Patent and Trademark Office (USPTO) has ... ICT-107, a dendritic cell-based immunotherapeutic vaccine targeting six ... The claims of US Patent No. 8,871,211, which ... neural cancer by administering a dendritic cell composition ...
(Date:12/15/2014)... , December 15, 2014 ... Am 19. und 20. Februar sind ... Aegate SAFE MEDICINE ECOSYSTEM PARTNER PROGRAMM ™ ... zu besuchen. Diese Tagung soll ... die Möglichkeit geben, die neue profitablen Unternehmensdienstleistungen, ...
Breaking Medicine Technology:Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 2Strategic Health Services to collaborate with QualCare on Population Health and Wellness Technology for QualCare Members 3ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
... May 24 Perrigo Company (Nasdaq: PRGO ; TASE) ... will present at the Citi Investment Research Global Health Care Conference on ... the New York Hilton.  The presentation will be webcast on the following ... , , ...
... , MOSCOW , May 24 The international forum "Drug ... held in Moscow on June 9 and 10, 2010, ... , Heads ... gather in Moscow for a conference initiated by the Russian News ...
Cached Medicine Technology:Drug Production in Afghanistan: A Challenge for the International Community 2
(Date:12/17/2014)... Marlborough, Mass. (PRWEB) December 17, 2014 ... College of Osteopathic Medicine (ACOM), which welcomed its ... Virtual Desktop Infrastructure (VDI) to seamlessly support bring ... learning – and teaching – experience. The solution, ... Citrix NetScaler , Dell server and storage ...
(Date:12/17/2014)... HeartMath® Inc., recognized as one of the world’s ... heart coherence and the physiology of emotions, is ... to chipset manufacturers and consumer electronics companies. The ... its HRV solutions, tap into its HRV sensor ... HRV databases and algorithms for developing consumer products. ...
(Date:12/17/2014)... 2014 In its comprehensive analysis of ... Argus Claim Review division have recently identified out-of-network and ... ways savings are achieved on behalf of employer-clients. ... dollars in savings to Argus each year, with a ... explained by Tom Doney, Cypress president and CEO, these ...
(Date:12/17/2014)... IL (PRWEB) December 17, 2014 Now ... Awards celebrate the best of the best in senior ... award is only given to communities and agencies that ... the SeniorAdvisor.com site. Of the nearly 100,000 providers currently ... award. Winners of the SeniorAdvisor.com Best of 2015 Awards ...
(Date:12/17/2014)... Dec. 15, 2014 (HealthDay News) -- As gas prices ... deaths, a new study suggests. In times of ... of those riders are inexperienced, the researchers explained. ... California, which has the highest number of motorcycle registrations ... of motorcyclist deaths. The analysis revealed a strong ...
Breaking Medicine News(10 mins):Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 2Health News:Alabama College of Osteopathic Medicine Deploys Desktop Virtualization Solution from Citrix, Dell and Unidesk 3Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 2Health News:HeartMath® Inc.’s HRV Platform Solutions Available for Licensing 3Health News:Out-of-Network & Medical Necessity Reviews among Top Ways TPA Identifies Significant Medical Claim Savings 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 3Health News:When Gas Prices Go Up, So Do Motorcycle Accidents, Study Finds 2
... of Michigan researchers have identified the first biomarker of ... a simple blood test that should solve a treatment ... after bone marrow transplants. The biomarker also makes it ... dying of graft-versus-host disease, or GVHD. GVHD is ...
... R. Palmer Beasley, M.D., Ashbel Smith Professor at The ... awarded the Hepatitis B Foundation,s Distinguished Scientist Award 2010. ... provides long-term protection against hepatitis B infection, which is ... the world. Ultimately, HBV can be eradicated," said Beasley. ...
... ... major concerns that could affect efforts to effectively implement electronic health records under ... (CHIME). , ... Ann Arbor, MI (Vocus) -- Reporting, product certification and implementation deadlines represent ...
... ... ... 20 years with very little innovation, the world of cast removal has changed. Sanford ... , , ,With an operating sound level just above a whisper, and no vibration, the ...
... Minn., Jan. 8 Grubb & Ellis Healthcare REIT II, ... to acquire the Center for Neurosurgery and Spine, a 36,600-square-foot, ... Sartell. The acquisition is subject to customary closing conditions and ... , Located at 162 19th St. South, the ...
... and benefit people with asthma, heart and lung disease, ... News) -- The U.S. Environmental Protection Agency on Thursday ... to a variety of health problems, including aggravated asthma ... , The new standards, if adopted by the agency ...
Cached Medicine News:Health News:Blood test could improve graft-versus-host disease treatment 2Health News:Blood test could improve graft-versus-host disease treatment 3Health News:CHIME Voices Concerns About Proposed ARRA Regulations 2Health News:CHIME Voices Concerns About Proposed ARRA Regulations 3Health News:CHIME Voices Concerns About Proposed ARRA Regulations 4Health News:New 'Kid-Friendly' Cast Removal Tool Now at Sanford 2Health News:Grubb & Ellis Healthcare REIT II Enters Agreement to Acquire the Center for Neurosurgery and Spine Near St. Cloud, Minn. 2Health News:Grubb & Ellis Healthcare REIT II Enters Agreement to Acquire the Center for Neurosurgery and Spine Near St. Cloud, Minn. 3Health News:Grubb & Ellis Healthcare REIT II Enters Agreement to Acquire the Center for Neurosurgery and Spine Near St. Cloud, Minn. 4Health News:EPA Unveils Stricter Smog Standards 2Health News:EPA Unveils Stricter Smog Standards 3
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... reagent provides a long shelf life ...
... Amylase powder reagent once reconstituted offers ... single liquid stability to help maximize ... provide quick result turnaround time. The ... powder reagent provides a long shelf ...
LCD chart display...
Mobile offers full life cycle service for Sp02 accessories that are the vital link between pulse oximeter and patient...
Medicine Products: